- Recursion Pharmaceuticals on Tuesday said results from a mid-stage trial showed its lead experimental drug to be safe, the first readout in a series of important data disclosures for the AI drug discovery specialist.
- But the summary findings Recursion announced provide little indication of whether the drug,…
Click here to view original postClick Here to Publish/Feature Your Company or Product News with Biotech Networks
dōTERRA Named Verified Market Leadership Award Winner in the Global Aromatherapy and Essential Oils Market
PLEASANT GROVE, Utah, March 31, 2025 /PRNewswire/ — Verify Markets, a global B2B market research and consulting firm, has awarded dōTERRA with the Market Leadership Award for exceptional achievement and continuous dominance in the Global […]
TheraLight Adds 360+ Model to Existing Line of Products
The new red light therapy bed brings additional power to the combined wavelengths of 633nm, 810nm, 850nm, and 940nm LINDON, Utah, July 29, 2024 /PRNewswire/ — TheraLight, LLC, a rapidly growing global leader in light […]
TruHearing® Announces Alliance with VFW
Veterans and Military Service Members Gain Access to Broad Range of Hearing Healthcare Benefits DRAPER, Utah, July 28, 2022 /PRNewswire/ — TruHearing, the market leader in hearing healthcare benefits¹, continues to expand access to hearing […]
